Assignee
L E A F HOLDINGS GROUP LLC
US·29 granted patents·39 pending applications·151 citations·filing 2015–2025
Top patents by PatentIndex Score
68 records- 0199US11701432B2Polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2022·Granted Jul 18, 2023·17 cites·32 claims
- 0299US11344628B2Alpha polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2017·Granted May 31, 2022·32 cites·36 claims
- 0398US12178883B2Alpha and gamma-D polyglutamated pemetrexed antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2021·Granted Dec 31, 2024·2 cites·30 claims
- 0498US11534498B2Polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2017·Granted Dec 27, 2022·29 cites·27 claims
- 0597US12178882B2Alpha polyglutamated pemetrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2021·Granted Dec 31, 2024·2 cites·19 claims
- 0697US12048766B2Gamma polyglutamated tetrahydrofolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Jul 30, 2024·14 cites·43 claims
- 0797US11779584B2Alpha polyglutamated pemetrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Oct 10, 2023·13 cites·38 claims
- 0897US11771700B2Gamma polyglutamated lometrexol and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Oct 3, 2023·11 cites·46 claims
- 0997US11730738B2Alpha polyglutamated pralatrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Aug 22, 2023·10 cites·47 claims
- 1096US12048767B2Gamma polyglutamated pralatrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Jul 30, 2024·10 cites·23 claims
- 1193US2025018055A1Alpha and gamma-d polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 1293US2025127920A1Gamma-d polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 1393US2025099608A1Polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 1492US12128046B2Alpha polyglutamated methotrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Oct 29, 2024·4 cites·21 claims
- 1592US12076402B2Alpha polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Sep 3, 2024·6 cites·52 claims
- 1692US2024390514A1Polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 1787US2023381338A1Polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2023·Application pending·0 cites
- 1885US12213981B2Alpha polyglutamated pralatrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2023·Granted Feb 4, 2025·0 cites·45 claims
- 1983US12201695B2Polyglutamated pemetrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2021·Granted Jan 21, 2025·0 cites·26 claims
- 2083US2025152511A1Platinum complexes and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 2183US2025195686A1D glutamate polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 2281US12433893B2Alpha polyglutamated pemetrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2023·Granted Oct 7, 2025·0 cites·25 claims
- 2381US2025161455A1Alpha polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 2480US12458597B2Carotenoid compositions and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Nov 4, 2025·1 cites·39 claims
- 2580US12296022B2D glutamate polyglutamated antifolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2022·Granted May 13, 2025·0 cites·27 claims
- 2679US2025177304A1Targeted liposomal gemcitabine and methods thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 2778US2025213476A1Gamma polyglutamated raltitrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 2877US2025082575A1Gamma polyglutamated pralatrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 2977US2025066468A1Liposome encapsulated affinity drugL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 3077US2025082639A1Alpha polyglutamated methotrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 3176US2025198442A1Gamma polyglutamated pemetrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 3275US12161757B2Platinum complexes and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2021·Granted Dec 10, 2024·0 cites·30 claims
- 3375US2024252498A1Gamma polyglutamated lometrexol and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2023·Application pending·0 cites
- 3475US2026053806A1Gamma polyglutamated methotrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 3575US2026053807A1Alpha polyglutamated aminopterin and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 3673US12290518B2Gamma polyglutamated methotrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted May 6, 2025·0 cites·23 claims
- 3772US2026014079A1Carotenoid compositions and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 3871US12336994B2Alpha polyglutamated tetrahydrofolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Jun 24, 2025·0 cites·20 claims
- 3969US12246019B2Alpha polyglutamated lometrexol and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Mar 11, 2025·0 cites·20 claims
- 4069US12115256B2Targeted liposomal gemcitabine and methods thereofL E A F HOLDINGS GROUP LLC·Filed 2021·Granted Oct 15, 2024·0 cites·24 claims
- 4169US2025064736A1Gamma polyglutamated tetrahydrofolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2024·Application pending·0 cites
- 4269US2026048054A1Alpha polyglutamated tetrahydrofolates and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 4368US2025213578A1Alpha polyglutamated aminopterin and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 4467US2019231690A1Platinum complexes and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2018·Application pending·0 cites
- 4567US2025213576A1Alpha polyglutamated pralatrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 4667US2025222001A1Gamma polyglutamated methotrexate and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2025·Application pending·0 cites
- 4765US12239734B2Gamma polyglutamated raltitrexed and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted Mar 4, 2025·0 cites·21 claims
- 4863US12310966B2Alpha polyglutamated aminopterin and uses thereofL E A F HOLDINGS GROUP LLC·Filed 2019·Granted May 27, 2025·0 cites·20 claims
- 4963US10940112B2Targeted liposomal gemcitabine compositions and methods thereofL E A F HOLDINGS GROUP LLC·Filed 2017·Granted Mar 9, 2021·0 cites·17 claims
- 5061US2025064768A1Methods and compositions for treating aging and chronic diseaseL E A F HOLDINGS GROUP LLC·Filed 2022·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when L E A F HOLDINGS GROUP LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →